Chargement en cours...

Oral Janus Kinase Inhibitor for the Treatment of Rheumatoid Arthritis: Tofacitinib

Since the introduction of immune modulators in the treatment of rheumatoid arthritis (RA), there has been hope that orally effective biologic agents would be developed. Tofacitinib, a Janus kinase inhibitor, has become the first oral biologic to receive approval for use in active RA patients. This p...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ni, Han, Moe, Soe, Myint, Kay Thi, Htet, Aung
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736471/
https://ncbi.nlm.nih.gov/pubmed/23970975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/357904
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!